Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors

Details Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors

C - Chemistry, Metallurgy

07

D

C07D 519/00 (2006.01) A61K 31/55 (2006.01) A61P 31/12 (2006.01)

Patent

CA 2651690

The invention encompasses compounds of formula (I) as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

L'invention concerne des composés répondant à la formule I ainsi que des compositions et des procédés d'utilisation des composés. Les composés sont actifs contre le virus de l'hépatite C (VHC) et peuvent être employés dans le traitement de patients infectés par le VHC.

Affiliated with

Also associated with

Rating

Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1508223